Stromal NRG1 in luminal breast cancer defines pro-fibrotic and migratory cancer-associated fibroblasts

HER3 is highly expressed in luminal breast cancer subtypes. Its activation by NRG1 promotes activation of AKT and ERK1/2, contributing to tumour progression and therapy resistance. HER3-targeting agents that block this activation, are currently under phase 1/2 clinical studies, and although they hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Berdiel-Acer, Mireia, Maia, Ana, Hristova, Zhivka, Borgoni, Simone, Vetter, Martina, Burmester, Sara, Becki, Corinna, Michels, Birgitta, Abnaof, Khalid, Binenbaum, Ilona, Bethmann, Daniel, Chatziioannou, Aristotelis, Hasmann, Max, Thomssen, Christoph, Espinet, Elisa, Wiemann, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049869/
https://www.ncbi.nlm.nih.gov/pubmed/33692466
http://dx.doi.org/10.1038/s41388-021-01719-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049869/
https://www.ncbi.nlm.nih.gov/pubmed/33692466
http://dx.doi.org/10.1038/s41388-021-01719-3

Ejemplares similares